250 related articles for article (PubMed ID: 15063407)
21. Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure.
Price JF; Towbin JA; Dreyer WJ; Moffett BS; Kertesz NJ; Clunie SK; Denfield SW
J Card Fail; 2006 Mar; 12(2):139-43. PubMed ID: 16520263
[TBL] [Abstract][Full Text] [Related]
22. Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home.
Lang CC; Hankins S; Hauff H; Maybaum S; Edwards N; Mancini DM
J Heart Lung Transplant; 2003 Apr; 22(4):419-26. PubMed ID: 12681419
[TBL] [Abstract][Full Text] [Related]
23. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
[TBL] [Abstract][Full Text] [Related]
24. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
[TBL] [Abstract][Full Text] [Related]
25. [Improvement of short-term prognosis in patients with refractory heart failure].
Boffa GM; Cannas S; Cacciavillani L; Marzari A; Grassi G; Bauce B; Livi U; Maddalena F
G Ital Cardiol; 1997 Oct; 27(10):1024-8. PubMed ID: 9410772
[TBL] [Abstract][Full Text] [Related]
26. Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
Gorski LA
Home Healthc Nurse; 2002 Apr; 20(4):244-53; quiz 253-4. PubMed ID: 11984193
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
28. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.
Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF
J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
[TBL] [Abstract][Full Text] [Related]
30. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
[TBL] [Abstract][Full Text] [Related]
31. Predictors of clinical outcome in advanced heart failure patients on continuous intravenous milrinone therapy.
Bhat G
ASAIO J; 2006; 52(6):677-81. PubMed ID: 17117058
[TBL] [Abstract][Full Text] [Related]
32. Outpatient dobutamine for end-stage congestive heart failure.
Miller LW; Merkle EJ; Herrmann V
Crit Care Med; 1990 Jan; 18(1 Pt 2):S30-3. PubMed ID: 2293976
[TBL] [Abstract][Full Text] [Related]
33. The value of intermittent inotropic therapy in unhospitalized patients with refractory heart failure.
Moga VD; Luca C; Luca CT; Branea H; Drăgulescu SI
Rom J Intern Med; 1999; 37(1):25-9. PubMed ID: 15523942
[TBL] [Abstract][Full Text] [Related]
34. Prognosis of alternative therapies in patients with heart failure not accepted for heart transplantation.
Lindelöw B; Andersson B; Waagstein F; Bergh CH
J Heart Lung Transplant; 1995; 14(6 Pt 1):1204-11. PubMed ID: 8719468
[TBL] [Abstract][Full Text] [Related]
35. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
36. Use of intravenous inotropic therapy in the home.
McCloskey WW
Am J Health Syst Pharm; 1998 May; 55(9):930-5; quiz 953-4. PubMed ID: 9588252
[TBL] [Abstract][Full Text] [Related]
37. Catecholamine support at the initiation of epoprostenol therapy in pulmonary arterial hypertension.
Akagi S; Ogawa A; Miyaji K; Kusano K; Ito H; Matsubara H
Ann Am Thorac Soc; 2014 Jun; 11(5):719-27. PubMed ID: 24716663
[TBL] [Abstract][Full Text] [Related]
38. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
Nishi K; Sato Y; Miyamoto T; Toma M; Taniguchi R; Fukuhara R; Saijo S; Fujiwara H; Takatsu Y
J Cardiol; 2012 May; 59(3):366-73. PubMed ID: 22365946
[TBL] [Abstract][Full Text] [Related]
39. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
Jellema WT; Groeneveld AB; Wesseling KH; Thijs LG; Westerhof N; van Lieshout JJ
Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]